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Accepted 24 January 2013AbstractObjective: To describe the treatment outcomes of aberrant ectopic implantations in the lower segment of the uterus in a cohort population and to
evaluate whether or not low-lying-implantation ectopic pregnancy (LLIEP), a new term, is appropriate to include in the traditional diagnoses of
cervical pregnancy (CP), cesarean scar pregnancy (CSP), and other unusual aberrant implantations in the lower segment of the uterus in the first
trimester, in terms of clinical characteristics, treatment, and prognosis.
Materials and methods: Forty-two women with ectopic pregnancies of <12 weeks’ gestational age from July 2003 to December 2008 were
prospectively studied. Each patient underwent an ultrasound evaluation by an experienced consultation team and was grouped into the CP, CSP,
or cervico-isthmic pregnancy (CIP) group. Patients underwent either suction dilatation and curettage (D and C) alone, or laparoscopic uterine
artery blockage followed by suction D and C, to remove the aberrant trophoblasts without other adjuvant treatments. Clinical characteristics and
biochemical factors, including obstetric history, patient age, body mass index (BMI), gestational age, serum hematocrit and b-hCG level,
operation method, operation time, and intraoperative blood loss were evaluated.
Results: There were no significant differences in patient age (mean ¼ 34.1  6.4 years), previous number of cesarean deliveries
(mean ¼ 1.5  0.8), gestational age (mean ¼ 6.9  1.2 weeks), serum b-hCG (mean ¼ 35,384.3  41,726.9 mIU/mL), operation time
(mean ¼ 60.3  46.6 minutes), and surgical blood loss (mean ¼ 124.7  191.5 mL) among the three patient groups. The uterus was successfully
preserved in all patients after treatment.
Conclusion: The prognosis of surgical management for ectopic implantations in the lower segment of the uterus is good. The new term LLIEP
seems appropriate to cover all forms of aberrant ectopic implantations in the lower segment of the uterus in the first trimester, in terms of
treatment efficacy. The use of LLIEP for preoperative ultrasound diagnosis would enable the clinician to diagnose unusual cases more easily,
without the need to change the current treatment policy.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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http://dx.doi.org/10.1016/j.tjog.2013.10.009Cervical pregnancy (CP) is a rare form of ectopic pregnancy
and its incidence is about 1 in 1000 to 1 in 18,000 live births
[1]. Previous therapeutic abortion, Asherman’s syndrome,
previous cesarean delivery, diethylstilbestrol exposure, pres-
ence of intrauterine devices, leiomyoma, structural abnor-
malities, and in vitro fertilization are risk factors for CP [2].
Ectopic cervical pregnancy was first diagnosed using ultra-
sound in 1978 [3]. With advances in ultrasound resolution and
wide use in clinical practice, CP can be detected in the early
stage. However, the definitive clinical diagnosis of CP wascs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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circumstances, CP has a high potential for morbidity, because
of the risk of catastrophic hemorrhage [5e7]. Management
options for the treatment of cervical ectopic pregnancy vary
from conservative medical therapies to radical surgical pro-
cedures [7,8]. Recently, mortality has dramatically decreased
because of early diagnosis and effective treatment options to
prevent life-threatening bleeding [5]. Nevertheless, the most
effective treatment methods for CP remain unclear.
Cesarean scar pregnancy (CSP) is another rare form of
abnormal pregnancy, with an incidence of 1/1800, which could
be life threatening and cause maternal morbidity [9]. Risk
analysis showed that 54% of these patients have undergone
multiple cesarean deliveries [10,11]. Catastrophic hemorrhage
may occur during surgical evacuation, because of the abnor-
mally high vascularity and varicosity in the anterior lower
segment of the uterus, especially with advancing gestation
[10]. The lower segment is less capable of fibromuscular
contraction to control bleeding [10]. Treatments for CSP
include simple suction dilatation and curettage (D and C),
systemic or local methotrexate (MTX) chemotherapy, trans-
cervical hysteroscopic resection, hysterotomy, uterine artery
ligation, and uterine artery embolization [11e16]. The diag-
nosis is often difficult and a false-negative diagnosis may
result in major complications [13]. There is still no consensus
on the method of choice for managing CSP [17]. Diagnosing
and treating CSP earlier rather than later shows a trend toward
an improved outcome [11,14,16].
Both CP and CSP were similar in incidence rarity, carried
the potential for life threatening bleeding, and had diverse
treatment options. Previously published studies are case re-
ports, which were with limited patient numbers [6,12,18]. In
clinical practice, the majority of clinicians have very limited
experience and confidence in the differential diagnosis and
treatment of these pregnancies and treatment is at the physi-
cians’ discretion. In this study, we described the treatment
outcomes of aberrant ectopic implantations in the lower
segment of the uterus, whether in the cervix, cervico-isthmus,
or a previous cesarean scar in a cohort population at a tertiary
referral hospital. Furthermore, we would like to introduce a
new term of low-lying-implantation ectopic pregnancy
(LLIEP), which includes all types of aberrant implantation in
the lower segment of the human uterus. Patient characteristics,
hematologic and serologic markers, operation parameters, and
prognosis after treatment were assessed in each group and
compared among the groups.
Materials and methodsPatient recruitmentPatients who were referred by local medical departments
due to suspicion of CP and CSP based on ultrasound exami-
nations and refusal to maintain the pregnancy were recruited
for further screening from 2003 to 2008. Previously, our
earlier results regarding the accuracy of ultrasound diagnosis
and the effectiveness of newly developed one-stagelaparoscopic management of cervical pregnancies were pub-
lished in 2004 [19]. In that report, we found that team
consultation effectively avoided ultrasound overdiagnosis and
a one-stage endoscopic treatment could give a promising
surgical prognosis in CP.Initial evaluation of CP and CSPEnrolled patients were reevaluated according to our estab-
lished protocol. Each pregnancy was reconfirmed by qualita-
tive detection of urinary b-hCG and secondarily by
quantitative measurement of serum b-hCG. The obstetrical
history of each patient was reviewed by the care-providing
physicians. Gestational age, calculated based on the last
menstrual period, was adjusted according to the previous
menstrual pattern, or estimated by ultrasound dating, as
appropriate. The uterine cervix was inspected with a bivalve
speculum on gynecological examination at the initial visit.Ultrasound diagnostic criteria of CPTransabdominal ultrasound was performed with a well-
distended bladder, to establish the diagnosis of CP using the
following criteria: (1) the presence of the gestational sac or
placental texture dominantly within the cervix; (2) no evi-
dence of intrauterine pregnancy; (3) visualization of an
endometrial stripe; (4) hourglass uterine shape with ballooned
cervical canal (for gestational age  7 weeks) as suggested by
Hofmann et al [20]; and (5) a gestational sac with active
cardiac motion, indicating a viable pregnancy below the in-
ternal os, as suggested by Timor-Tritsch et al [21]. Fig. 1A
shows a typical case of CP by transabdominal ultrasound.
Transvaginal ultrasound was alternatively or complementarily
used in the same examination. Transvaginal ultrasound with an
empty bladder was also used to localize and measure the
gestational mass and/or sac, if present.
During vaginal scanning, gentle pressure was applied on
the cervix using an ultrasound probe to rule out “abortion in
progression with abortus retained by a resistant external os,”
also referred to as the “sliding sign.” Additionally, we used the
presence or absence of fetal cardiac activity, shape of the
gestational sac, color Doppler flow mapping around the
gestational sac, and gentle movement of the cervix by using an
ultrasound probe to help differentiate abortion in progress
from CP.Ultrasound diagnosis of CSPThe diagnosis of CSP by ultrasonography requires the
presence of the following criteria: (1) an empty uterus, with a
clearly demonstrated endometrium; (2) an empty cervical
canal; (3) a gestational sac located in the anterior part of the
uterine isthmus; and (4) a gestational sac, with or without
cardiac activity, embedded in and surrounded by the myo-
metrium and the fibrous tissue of a previous cesarean scar,
separate from the endometrial cavity or fallopian tube [13,22].
Fig. 1. Transabdominal ultrasound images showing: (A) An 8-week-1-day cervical pregnancy in which the uterus is hourglass-shaped, with an empty endometrial
cavity and peripheral hypervascularity around the intracervical mass (increased vessel flows, Doppler imaging, arrow). No fetus is visible. (B) A 7-week-6-day
cesarean scar pregnancy with the sac embedded in the scar (arrow), protruding into the uterine cavity, with upward bulging toward the posterior wall of the
urinary bladder. (C) An 8-week-3-day cesarean scar pregnancy with cervico-isthmus involvement, with the sac (arrow) between the lower segment and the upper
cervix and a viable fetus inside the sac. (D) An 8-week (based on last menstrual period) undifferentiated lower segment pregnancy with an elongated, collapsed sac,
without an embryo (arrow), located between the lower segment and the uterine cervix.
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with cervico-isthmus involvement.
Color Doppler imaging was optionally applied for blood
velocimetry of the gestational mass and surrounding tissues.
The need for differentiation of the four types of abnormal
implantation low on the uterine corpus and cervix, including
CSP, abortion in progress, low-lying implantation/cervico-
isthmic pregnancy (CIP), and CP was kept in mind during the
ultrasound examination. To eliminate the care providers’
personal prejudices, minimize interobserver variations, and
enhance the interpretative accuracy, the final diagnosis of CP,
CSP, undifferentiated diagnosis, and abortion in progression
was made only if both the first author and at least one of the
coauthors agreed, based on evaluation of the b-hCG mea-
surements and ultrasound images.
For patients who did not meet the ultrasound criteria for
diagnosis of CP or CSP, or had a controversial diagnosis, but
had implantation between CP and CSP, or patients for whom
abortion in progress was excluded, the diagnosis of CIP was
made. Fig. 1D shows a gestational sac without an embryo,
located between the lower segment and the uterine cervix,
which was categorized as CIP.Clinical managementEach patient was informed of the treatment methods,
including conservative treatment with MTX chemotherapy andsurgical intervention. The benefit of MTX chemotherapy is
that it precludes the need for anesthesia and surgery; however,
MTX therapy carries the risk of failure, or requires possible
use of additional procedures, and a long time of outpatient
follow-up, based on previous experiences [14,23]. By contrast,
the one-stage minimally invasive surgery included: (1) gentle
suction D and C without vigorous curettage on the lower
segment of the uterus, with the assistance of transabdominal
ultrasound guidance; and (2) laparoscopic uterine artery
blockage followed by suction D and C [19]. The rationale for
laparoscopic uterine blockage in the treatment of LLIEP was
to reduce uterine perfusion and to achieve venous stasis in the
uterus. A suction D and C under laparoscopically direct
visualization was subsequently performed to remove the
gestational tissue [19]. Preoperative informed consent was
obtained about the possible need for conversion to laparo-
scopic uterine artery ligation, or even hysterectomy during D
and C in the case of uncontrollable massive hemorrhage.
Most patients agreed to take one-stage minimally invasive
surgery after the explanation. The definition of successful
treatment was complete preservation of the uterus, without
additional surgical procedures.
After surgical management, we subdivided LLIEP patients
into simple and complicated groups. Those patients who
received suction D and C alone were grouped as simple, and
those who underwent a combination of laparoscopic uterine
blockage and suction D and C were grouped as complicated.
Table 1
Clinical characteristics in patients with cervical pregnancy (CP), cesarean scar pregnancy (CSP), and cervico-isthmic pregnancy (CIP).
CP (n ¼ 8) CSP (n ¼ 30) CIP (n ¼ 4) Total (n ¼ 42) p
Age (y) 30.4 35.1 34 34.1  6.4 0.149
Gravida 2.7 4.1 3.3 3.8  1.9 0.427
Parity 1.1 1.8 1.3 1.7  0.8 0.506
Previous abortions (n) 1.5 2.1 2.0 2.0  1.5 0.485
Previous cesarean deliveries 1.1 1.7 1.5 1.5  0.8 0.378
Body height (cm) 161.1 157.6 161 158.6  4.9 0.643
Body weight (kg) 52.1 54.7 65.3 55.3  9.2 0.057
Body mass index 20.1 21.8 25.3 21.8  3.3 0.015
Gestational age (wk) 6.6 6.8 8 6.9  1.2 0.867
Fetal heart beat (n)
Yes 1 11 1 13
No 7 19 3 29
Serum b-hCG (mIU/mL) 11,913.2 43,046.1 22,486.8 35,384.3  41,726.9 0.142
Surgical method
D and C alone (n) 4 22 4 30
Uterine artery blockadea with or without D and C (n) 3 8 0 11
Systemic MTX injection (n) 1 0 0 1
Operation time (min) 42.7 67.1 28.7 60.3  46.6 0.821
Blood loss (mL) 162 125 70 124.7  191.5 0.740
Total ¼ sum of CP, CSP, and CIP groups.
Data are presented as mean, mean  SD or value.
D and C ¼ dilatation and curettage; MTX ¼ methotrexate.
a Uterine artery blockade: 10 with laparoscopic uterine artery ligation and one with radiologic uterine artery angioembolization.
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Comparison of clinical characteristics and prognostic indicators between
viable and non-viable “low-lying-implantation ectopic pregnancy” groups.
Viable: presence of fetal heart beats.
Viable (n ¼ 13) Non-viable (n ¼ 29) p
Age (y) 35.8  7.0 33.1  6.5 0.144
Gravida 3.7  1.9 4.1  2.2 0.292
Parity 1.9  0.5 1.6  0.9 0.138
Previous abortions 1.6  1.9 2.4  1.4 0.129
Previous cesarean
sections
1.6  0.6 1.5  1.0 0.385
Body height (cm) 157.0  5.6 159.2  4.8 0.141
Body weight (kg) 53.1  10.9 56.7  7.8 0.167
Body mass index 21.5  4.1 22.1  2.6 0.346
Gestational age 7.1  1.0 6.8  1.2 0.216
Serum b-hCG
(mIU/mL)
52,180  45186.7 19,469.2  23341.5 0.021
Operation time (min) 55.9  29.6 75.1  60.1 0.123
Blood loss (mL) 123.3  217.9 135.5  207.2 0.439
Non-viable: absence of fetal heart beats.
Data are presented as mean  SD or value.All data were analyzed using SPSS software (version 13;
SAS Institute, Cary, NC, USA). A one-way analysis of vari-
ance was conducted to evaluate the relationship between
clinical characteristics in patients, and treatments (CP, CSP,
CIP, and total). Data were expressed as means  standard
deviations or percentages. A p value of  0.05 was considered
statistically significant.
Results
A total of 47 patients were transferred to our hospital from
seven private clinics and six community hospitals during the 5-
year study period. Eight patients (17.0%) fulfilled the
ultrasound-based criteria for CP, 30 patients (63.8%) for CSP,
four patients (8.5%) for undifferentiated diagnoses, and five
patients (10.6%) for abortion in progress. After exclusion of
the five patients with abortion in progress, 42 patients met our
criteria for LLIEP. Most of them presented with painless
vaginal spotting/bleeding. Of the 42 patients, 30 underwent
suction D and C alone as the treatment modality, after being
informed about the treatment options and discussion with
patients and/or their families. Eleven of the 42 patients un-
derwent uterine artery blockade with or without suction D and
C. Only 1 of the 42 patients received systemic MTX treatment.
Table 1 shows the clinical characteristics of the patients,
including patient age, gestational age, body mass index (BMI),
body height, obstetric history, operation time, operation
method, amount of operative blood loss, and serum b-hCG
level at diagnosis. Thirty patients, including four patients with
cervical pregnancies, 22 with CSP, and four with CIP, under-
went suction D and C alone. By contrast, 11 patients,including three patients with cervical pregnancies and eight
patients with CSP, underwent uterine artery blockade with or
without suction D and C. The mean operation time for patients
undergoing surgical intervention was 60.3 (46.6) minutes
and their mean blood loss was 124.7 (191.5) mL. There were
no statistically significant differences in all variables among
the CP, CSP, and CIP groups.
Table 2 shows a comparison of the clinical characteristics
and prognostic parameters between the 15 patients with defi-
nite fetal heartbeats (viable) and the 29 without fetal heart-
beats (non-viable). There were no statistically significant
differences in variables except for the serum b-hCG level
Table 3
Comparison of clinical characteristics and prognostic indicators between







Age (y) 35.7  5.2 31.6  6.9 0.038
Gravida 3.6  1.8 4.2  2.2 0.229
Parity 1.6  0.8 1.8  0.8 0.202
Previous abortions 2.1  1.4 2.0  1.6 0.428
Previous cesarean
sections
1.6  0.7 1.5  0.8 0.312
Body height (cm) 158.7  3.8 158.5  6.8 0.458
Body weight (kg) 56.1  9.4 54.3  8.7 0.276
Body mass index 22.1  3.5 21.5  3.1 0.305
Gestational age 6.6  1.0 7.5  1.3 0.056
Serum b-hCG
(mIU/mL)
72,798.7  39,594.9 41,932.3  48,478.7 0.296
Operation time (min) 39.2  17.9 105.8  57.1 0.001
Blood loss (mL) 96.2  168.9 186.1  227.2 0.112
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higher in the viable fetus group.
Table 3 shows a comparison of clinical characteristics and
operation parameters between simple and complicated LLIEP
groups. There were significant differences in age (35.7  5.2
vs. 31.6  6.9 years) and operation time (39.2  17.9 vs.
105.8  57.1 minutes). Those patients with complicated
LLIEP were younger and had a longer operation time.
Discussion
In this prospective study, aberrant gestation in the lower
segment of the uterus occurred mostly on previous cesarean
scars (63%, 30/47) and secondly in the cervix (17%, 8/47),
based on our ultrasound diagnosis. The incidence of CSP was
higher than that of CP at our institution, which is compatible
with previous studies [14,24]. With increases in the numbers
of cesarean deliveries, the likelihood of CSP is expected to
continue [11].
In the past few decades, the diagnosis of aberrant gestation
in the lower segment of the uterus is based almost solely on
ultrasound findings rather than surgical and anatomicFig. 2. The circled area with the letters a, b, and c inside indicate various
low-lying-implantation ectopic pregnancy (LLIEP) anatomic locations:
a ¼ cesarean scar pregnancy; b ¼ cervical-isthmus pregnancy; c ¼ cervical
pregnancy.examinations. CSP were often misdiagnosed as low intra-
uterine pregnancies, CP, or miscarriage in progress [11,18]. In
clinical practice, the ultrasound-based term of LLIEP is
probably suitable for use in terms of clinical characteristics,
response to treatment, and the final outcome after treatment.
LLIEP represents a cluster of diagnoses, including CSP, CIP,
and CP (Fig. 2).
From the embryonic and anatomic points of view, the
cervix and lower segment of the uterus originate from the
distal paramesonephric ducts in the development. Upon
maturation, the muscular content of the myometrium in this
anatomic part becomes less, compared to the corpus of uterus,
but receives the same blood supply, mainly from the uterine
arteries, and has similar innervation. In establishment of
human gestation, embryo nidation can occur on any location
along the lower uterine cavity and endocervical canal. From
the clinical manifestation point of view, most LLIEP during
the first trimester present as abnormal painless vaginal
bleeding, but carry the potential risk of uncontrollable
bleeding, with less capability of muscular contraction, and
require time-consuming resolution of the lesion with a pro-
longed recovery time. Zhang et al found that 82% patients of
CSP presented with light vaginal bleeding, which agrees with
our finding [12]. A cluster of abnormal gestations are suitable
for a diagnosis of LLIEP.
With its preciseness in determining implantation location
and size and in visualizing surrounding tissue and organs,
conventional two-dimensional ultrasound imaging with alter-
nate use of abdominal and/or vaginal approaches to diagnose
LLIEP was suitable for the vast majority of the cases. Trans-
abdominal ultrasound with a well-distended urinary bladder
provides good visualization of the uterus and cervix in one
single plane. Transvaginal ultrasound with an empty bladder
allows detailed imaging by adjusting ultrasonic frequencies in
cases of early or small LLIEP. Placental implantation in
LLIEP along the low segment, isthmus, internal os, and
endocervical canal can be identified. Doppler ultrasound can
demonstrate vascular communications between the uterine
stroma and placenta, and is helpful to differentiate abortion in
progress from LLIEP. Power Doppler and/or three-
dimensional ultrasound examination provides additional in-
formation for monitoring and quantifying neovascularization
change for the initial diagnosis and during the follow-up
period [25,26], but are not essential in most cases for the
initial diagnosis [19].
Clinically, both CP and CSP are usually misdiagnosed
[1,2,12,18]. CP is sometimes mistaken as threatened abortion
if the patient’s presenting symptom is mild to moderate
vaginal bleeding [1,6]. Only heavy vaginal bleeding arouses
clinical suspicion of CP [1]. Unfamiliarity with these types of
pregnancies among physicians in the community often results
in misdiagnosis and inadequate management [27]. If the
delayed diagnosis of CSP and CP are grouped to noncompli-
cated LLIEP, the prognosis might not be poorly affected.
However, if these ectopic pregnancies are grouped into the
complicated type of LLIEP, morbidity and prognosis could be
worse when the diagnosis is delayed.
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on which treatment is the most effective, especially for LLIEP
during the first trimester. Literature reviews showed that both
conservative treatment and aggressive treatment provide good
prognoses [3,6,8,18,23,27]. Conservative medical treatment,
such as systemic MTX or systemic MTX with local KCl in-
jection, are reported and proved to be a feasible management
option for CP or CSP [27]. In the present study, we used
suction D and C as the first-line treatment for patients with
CSP, CP, or ULSP, because most of the gestational ages fell
within the first trimester, and the ectopic mass was small and
simple. A gentle suction D and C procedure was effective and
safe. For those patients with complicated cases, laparoscopic
blockade of the uterine artery in conjunction with D and C
under laparoscopic visualization was needed to avoid intra-
operative D and C-related heavy bleeding. Both of the above
methods gave the advantage of en bloc removal of tropho-
blastic tissues in one procedure, without the need for further
MTX chemotherapy [19].
The uterus was successfully preserved after treatment in all
patients. Furthermore, we found no statistically significant
differences between patients with (viable) and without
(nonviable) fetal heartbeats (Table 2); thus, fetal heart activity
might not affect patient prognosis in the first trimester. How-
ever, because the case number is small due to the rarity of
LLIEP, confirmation of this observation is needed.
Fifteen (35%) of 42 patients with an original presumptive
diagnosis from the local clinics and community hospitals were
inconsistent with the diagnosis made in our department. In our
previous study [19], only six (22%) of 27 patients referred for
suspicion of CP had a final diagnosis of the condition on re-
view by an experienced ultrasound consultation team. In a
study by Shavell et al, 75% patients with CP were initially
misdiagnosed [1]. In a study by Vela and Tulandi, initial
diagnosis of CP was correct in five of 12 patients [6]. In a
review by Timor-Tritsch and Monteagudo, the diagnosis of
CSP was missed in 107 of 751 cases [11]. By contrast, in
reality, a single diagnosis of CSP, CP, or CIP could overlap
with, or involve the others in various degrees. Taking into
account the above observations, the clinical application of
LLIEP can be convenient to cover all of the aberrant ectopic
implantation situations in the lower segment of the uterus in
the first trimester.
The 42 study participants in this report were in the first
trimester of their pregnancies. The sample size was small;
therefore, comparison between or among the groups should be
made with caution, due to the lack of statistical power. Efforts
should be made to collect more cases to avoid bias and to have
other researchers from different institutions examine the
appropriateness in the manner of cooperation. Nonetheless,
LLIEP appears to be a useful and practical term covering all
forms of aberrant embryo implantation in the lower segment of
the uterus diagnosed with ultrasound. LLIEP is also useful
when applied to treatment method selection, without deterio-
rating efficacy, and in prediction of posttreatment recovery.
The use of LLIEP would help clinicians: (1) diagnose the rare
forms of lower segment ectopic pregnancies by ultrasound in asimple manner; (2) communicate with colleagues easily; (3)
explain the condition to patients in a simple and friendly
manner; and (4) choose the appropriate treatment plan without
the need to alter existing policies and procedures.References
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